High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 452 participants.
Also called NCT07059728
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 452 participants
- Sponsor
- Registry
-
NCT07059728
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07059728. Randomized; no masking; primary purpose supportive care. Start 2027-01-01 (anticipated); primary completion 2028-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II
- Condition
- Aortic Stenosis Treated With TAVI
- Condition
- Sedation; Aged; Hemodynamics
- Intervention (Device)
- Oxygen therapy during sedation provided via high nasal cannulae (60L/min at 60% FiO2)
- Intervention (Device)
- Oxygen therapy during sedation delivered via nasal cannulae at 5L/min
- Lead sponsor
- Hospital Clinic of Barcelona
Record details
- Record id
cardio:ct-nct07059728- Content hash
722767c7be80ae862acc45323218cc06d1d7dd85a3b0effaeb98f5310e008532